In a systematic literature search, MAGE-A6 was also significant in thymoma, esophageal adenocarcinoma, and kidney renal papillary cell carcinoma, while MAGE-A11 was in pheochromocytoma and paraganglioma64. Here, MAGEA11 is linked to pheochromocytoma.